SmartCraft fortsätter leverera bra kvartal med hög tillväxt och fin marginalutveckling.
Elanders levererade ett starkt resultat under Q4 och genomför åtgärder för förbättrad lönsamhet men ...
Q4 earnings were below our forecast, but there were clear positives in the report including a growin...
Company expects positive '23 Germany EBIT, ABGSCe SEK 22m Ferronordic reported Q4 EBIT from Germany ...
Staffing shortages in Q4 likely hurt volumes We cut '22e-'24e sales by 5-20% We have a positive view...
Q4 in brief The fourth quarter came in slightly below what we had expected, as Algo royalties were d...
Första intrycket Spotlight Group, kv4 2022: Intäkter över förväntan men stor kostnadsbas tyngde resu...
Heady growth continued in H1’22, but H2’22 was slower Exel’s Q4 revenue landed at EUR 31m vs the EUR...
Despite a below expectations Q4, at least partly due to increased sickness-related absences, we see ...
Pihlajalinna’s profitability challenges continued to be way worse in Q4 than estimated.
Göteborgsbaserade investmentbolaget Northern CapSek Ventures AB (”CapSek”) portföljbolag Klash Studi...
Redeye provides an update in relation to Optomed’s Q4 2022 report.
There will be two alternative IgAN therapies on the US market by the last week of February 2023 as t...
Redeye believes Transtema’s settlement agreement with GlobalConnect is reasonable.
Redeye retains its positive view of Speqta despite slightly lowering its forecast and Base Case.
Q4 NOI beat of 10% filtering through Highest occupancy in the Swedish RE sector P/NAV at ~0.
Smart High Tech publicerade den 17 februari 2023 bolagets delårsrapport för det fjärde kvartalet 202...
Gynnas av en diversifierad affär Clemondo avslutade det händelserika året 2022 med en omsättning på ...
Redeye notes a continuous customer base growth (+72%), and we are encouraged by the company’s FDA ap...
Redeye comments on Jondetech’s excersice of warrants, which was subscribed to almost 55% and bringin...
